medEctoin® in Female Health
Providing confidence and comfort: Give women the option to choose a natural solution for vaginal dryness and vaginal atrophy that outperforms hyaluronic acid.
Clinical Claims
Enhancing Intimate Health
Instant effect, long-lasting relief: medEctoin® supports intimate care by effectively hydrating dry vaginal mucosa and reducing inflammation, providing a natural treatment option for adult woman of every age.
-
Immediate* Hydration of Dry Vaginal Mucosa and Prevention of Further Dehydration.
medEctoin® effectively retains moisture, helping to alleviate dryness in the vaginal area, which can occur due to hormonal changes, menopause, or certain medical conditions.
*(10 – 15 min)
-
Immediate* Alleviation of Vaginal Atrophy Symptoms With Long-Lasting Effect (Up to 5 Days).
For women experiencing vaginal atrophy due to menopause, medEctoin® can help relieve associated symptoms such as dryness, burning, and discomfort during intercourse.
*(10 – 15 min)
-
Reduction of Inflammation of the Vaginal Mucosa.
The potent inflammation-reducing properties of medEctoin® help soothe irritation and inflammation in the vaginal and vulvar areas, providing relief from discomfort and redness.
-
Maintenance of pH Balance Inside the Vagina.
medEctoin® helps maintain a healthy pH balance in the vaginal environment, which is essential for preventing infections and promoting overall intimate health.
-
Support of the Regeneration Process of the Irritated Vaginal Mucosa.
medEctoin® promotes the repair of damaged tissues by stabilizing cellular membranes, aiding in the self-healing of the delicate intimate area.
Clinically Proven:
medEctoin® in Intimate Care
Outperforming hyaluronic acid: Our clinical study could prove a variety of benefits of our medEctoin® Vaginal Gel for woman suffering from vaginal atrophy and dryness.
Instant Relief of Vaginal Atrophy Symptoms in Minutes
Participants
155 (efficacy population 135, safety population 155).
Duration
20 days treatment (V3-EoT) + 3-5 days follow-up (V4-FU).
Method
Assessment by Gynaecologist and patients.
Treatment
155 patients used medEctoin® Vaginal Gel for 20 days, as per instruction for use
and a follow up was conducted 3-5 days after the end of treatment.
Ask an Expert
Prof. Dr. Ralph Mösges was the chairman of the International Standardization Committee for the Objective Assessment of the Upper Airways (ISCOANA), a task force of the International Rhinologic Society (IRS) and serves as a member of the guidelines committee of the German Academy of Otorhinolaryngology.
Success Stories
Join the Success Story of medEctoin®:
License Our Creams Under Your Brand
Your logo could soon be featured on these products – and all in just 8 months. Learn more about claims and applications by clicking on the product of your choice.
